Methylation alteration of SHANK1 as a predictive, diagnostic and prognostic biomarker for chronic lymphocytic leukemia.

MLA

Loi, E., et al. Methylation Alteration of SHANK1 as a Predictive, Diagnostic and Prognostic Biomarker for Chronic Lymphocytic Leukemia. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1340014795&authtype=sso&custid=ns315887.

APA

Loi, E., Moi, L., Fadda, A., Satta, G., Zucca, M., Sanna, S., Amini Nia, S., Cabras, G., Padoan, M., Magnani, C., Miligi, L., Piro, S., Gentilini, D., Ennas, M., Southey, M., Giles, G., Wong Doo, N., Cocco, P., & Zavattari, P. (2019). Methylation alteration of SHANK1 as a predictive, diagnostic and prognostic biomarker for chronic lymphocytic leukemia.

Chicago

Loi, E, L Moi, A Fadda, G Satta, M Zucca, S Sanna, S Amini Nia, et al. 2019. “Methylation Alteration of SHANK1 as a Predictive, Diagnostic and Prognostic Biomarker for Chronic Lymphocytic Leukemia.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1340014795&authtype=sso&custid=ns315887.